Meeting summaries of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB)

Herbal medicinal product: Lecithinum ex soya, Glycine max (L.) Merr., P: Draft published

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Zepzelca, lurbinectedin, Date of authorisation: 29/05/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 24, Status: Authorised

New product information wording: extracts from PRAC recommendations on signals adopted at the 12-15 January 2026 PRAC

Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Date of authorisation: 30/06/2013, Revision: 26, Status: Authorised

Minutes - HMA-EMA joint Network Data Steering Group meeting - 15 April 2026

Human medicines European public assessment report (EPAR): Kapruvia, difelikefalin, Date of authorisation: 25/04/2022, Revision: 5, Status: Authorised

Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026